REFERENCES
- Agurell , S. , Halldin , M. , Lindgren , J. E. , Ohlsson , A. , Widman , M. , Gillespie , H. and Hollister , L. 1986 . Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man. . Pharmacol Rev , 38 ( 1 ) : 21 – 43 .
- Association, British Medical. 1997 . Therapeutic uses of cannabis. Amsterdam : Harwood Academic Publishers. .
- Baker , P. B. , Gough , T. A. and Taylor , B. J. 1983 . The physical and chemical features of Cannabis plants grown in the United Kingdom of Great Britain and Northern Ireland from seeds of known origin—Part II: Second generation studies. . Bull Narc , 35 ( 1 ) : 51 – 62 .
- “ Lords, House of. 1998 ” . In Cannabis: The scientific and medical evidence. London : House of Lords Select Committee on Science and Technology, Stationery Office. .
- Maykut , M. O. 1985 . Health consequences of acute and chronic marihuana use. . Prog Neuropsychopharmacol Biol Psychiatry , 9 ( 3 ) : 209 – 38 .
- McPartland , J. M. and Russo , E. B. 2001 . Cannabis and cannabis extracts: Greater than the sum of their parts? . J Cannabis Therap , 1 ( 3–4 ) : 103 – 132 .
- Pharmaceuticals, GW. 2002 . Investigators brochure for cannabis based medicine extract (CBME) Porton Down : GW Pharmaceuticals. .
- Portenoy , R. K. 1990 . Chronic opioid therapy in nonmalignant pain. . J Pain Symptom Manage , 5 ( 1 Suppl ) S46–62
- Porter , J. and Jick , H. 1980 . Addiction rare in patients treated with narcotics. . N Engl J Med , 302 ( 2 ) : 123
- Whittle , B. A. , Guy , G. W. and Robson , P. 2001 . Prospects for new cannabis-based prescription medicines. . J Cannabis Therap , 1 ( 3–4 ) : 183 – 205 .